PharVision Advisers’s Inspire Medical Systems INSP Stock Holding History

PharVision Advisers’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,358	Closed	-$402K	–	367
2025 Q4	$402K	Buy	+4,358	New	+$417K	0.2%	124

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

PharVision Advisers's INSP Position: Q1 2026 in Review

PharVision Advisers sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 4,358 shares — an estimated $402K sold.

PharVision Advisers first reported a position in INSP in Q4 2025 and held it in 1 quarter. The position peaked at $402K in Q4 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

PharVision Advisers reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 4,358 Inspire Medical Systems shares in Q1 2026, an estimated $402K.
PharVision Advisers first reported a position in Inspire Medical Systems in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Inspire Medical Systems position peaked at $402K in Q4 2025.
301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.